|
|
End of day quotes updated Fri Jan 16 15:46 CST
🏠
🔍
|
| 07-Oct-2025 |
106.91 |
0.00 {0.0 %} |
V: 0 |
|
| VRNA |
07-Oct-2025 |
Close: 106.91 |
0.00 {0.0 %} |
Volume: 0 |
|
|
|
|
|
|
|
|
22-Sep-2025
18-Jul-2025
31-Jan-2024
30-Dec-2022
|
|
|
|
|
|
VRNA
|
SPY
|
|
0
|
-0.1
-0.3
1.4
1.4
1.4
|
|
% Price Gain
WTD Performance (%)
MTD Performance (%)
QTD Performance (%)
YTD Performance (%)
|
SPY tracks S&P 500 index.
|
|
15 minute intraday candlestick chart, ~15 minute delay
15 minute intraday candlestick chart, ~15 minute delay
|
| VRNA News | 9-Jul-2025 5:30 AM CST - Business Wire
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next Decade
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Verona Pharma plc (Nasdaq: VRNA) (Verona Pharma), a biopharmaceutical company focused on respiratory diseases, today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Verona Pharma for $107 per American Depository Share (ADS), each of which represents eight Verona Pharma ordinary shares, for a tota | | | |
Disclaimer
Privacy
Contact
Copyright © 2001-2025, All rights reserved.
HotCandlestick.com, LLC
|
